About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

High Blood Pressure Strategy (HBPS) | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT00446914

High Blood Pressure Strategy (HBPS)

This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy br...

Lead sponsor: Heart and Stroke Foundation of Ontario•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Sheldon W Tobe, MD, FRCP(C)

CONTACT

416-480-6901 sheldon.tobe@sunnybrook.ca

Sponsors

Lead Sponsor

Heart and Stroke Foundation of Ontario

Collaborators

Sunnybrook Health Sciences Centre

Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults aged 18 years or older
•History of elevated BP reading or primary hypertension diagnosis

Exclusion Criteria

•Major mental health illness of cognitive impairment
•Language barrier (unable to speak or read English)
•Lives in a long-term care home
•Secondary hypertension

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981 · Pulmonary Arterial Hypertension

Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Heat and Air Pollution

NCT07606859 · Hypertension Arterial, 65 Years Older

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Regional Innovation in Chronic Disease and Elderly Care

NCT07578090 · Hypertension, Cardiovascular Disease, and more

Microplastics, Cirrhosis and Portal Hypertension

NCT07280390 · Cirrhosis, Microplastics, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 19, 2008Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment5,000

Start dateJan 2007

Last updatedAug 19, 2008

Condition

Locations shown

Heart and Stroke Foundation of Ontario

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 19, 2008Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions